ID

34481

Description

SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN); ODM derived from: https://clinicaltrials.gov/show/NCT01953055

Link

https://clinicaltrials.gov/show/NCT01953055

Keywords

  1. 1/17/19 1/17/19 -
  2. 5/22/19 5/22/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT01953055

Eligibility Prostate Cancer NCT01953055

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained
Description

ID.1

Data type

boolean

men > 18 years of age
Description

ID.2

Data type

boolean

histologically confirmed prostate adenocarcinoma (centrally reviewed)
Description

ID.3

Data type

boolean

high risk prostate cancer, defined as at least one of clinical stage t3 or gleason 8-10, or psa > 20ng/ml
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior pelvic radiotherapy
Description

ID.5

Data type

boolean

anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Description

ID.6

Data type

boolean

diagnosis of bleeding diathesis
Description

ID.7

Data type

boolean

large prostate (>90cm3) on imaging at time of gold seed insertion
Description

ID.8

Data type

boolean

no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l
Description

ID.9

Data type

boolean

definitive regional or distant metastatic disease on staging investigations
Description

ID.10

Data type

boolean

Similar models

Eligibility Prostate Cancer NCT01953055

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
informed consent obtained
boolean
ID.2
Item
men > 18 years of age
boolean
ID.3
Item
histologically confirmed prostate adenocarcinoma (centrally reviewed)
boolean
ID.4
Item
high risk prostate cancer, defined as at least one of clinical stage t3 or gleason 8-10, or psa > 20ng/ml
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
prior pelvic radiotherapy
boolean
ID.6
Item
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
boolean
ID.7
Item
diagnosis of bleeding diathesis
boolean
ID.8
Item
large prostate (>90cm3) on imaging at time of gold seed insertion
boolean
ID.9
Item
no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l
boolean
ID.10
Item
definitive regional or distant metastatic disease on staging investigations
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial